,MULTIPLE CHOICE mv
1. Knowledge of pharmacology aids the dental professional in
mv mv mv mv mv mv mv
a. obtaining a patient’s health history. mv mv mv mv
b. administering drugs in the office. mv mv mv mv
c. handling emergency situations. mv mv
d. selection of a nonprescription medication. mv mv mv mv
e. All of the above. mv mv mv
ANS: E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
of pharmacology helps in understanding and interpreting patients’ responses to health history questi
mv mv mv mv mv mv mv mv mv mv mv mv
ons. Knowledge of the therapeutic and adverse effects of medications obviously helps in their prop
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
er adm inistration in the office. Emergency situations may be caused by drugs or treated by drugs;
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
thus, kno wledge of pharmacology is of great help, especially because a rapid response is sometim
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
es required. A clear understanding of the concepts of drug action, drug handling by the body, and
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
drug interaction s will allow the dental practitioner to make proper judgments and grasp the concep
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ts relevant to new drug therapies on the market.
mv mv mv mv mv mv mv mv
DIF: Application m v
REF:
Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medicatio n
m v mv mv mv mv mv mv mv mv mv mv mv mv mv mv
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist (No
mv mv mv mv mv mv mv mv mv mv mv mv mv
nprescription Medication) | pp. 2-3
mv OBJ: mv1 mv mv mv
TOP: NBDHE, 6.0. Pharmacology m v mv mv
2. Which of the following statements is true regarding planning appointments?
mv mv mv mv mv mv mv mv mt
a. Whether or not patients are taking medication for systemic diseases is of litt
mv mv mv mv mv mv mv mv mv mv mv mv
le consequence in the dental office.
mv mv mv mv mv
b. Asthmatic patients should have dental appointments in the morning. mv mv mv mv mv mv mv mv
c. Diabetic patients usually have fewer problems with a morning appointment c
mv mv mv mv mv mv mv mv mv mv
o mpared with afternoon appointments.
mv mv mv mv
d. Both B and C are true. mv mv mv mv mv
ANS: D
Asthmatic patients who experience dental anxiety should schedule their appointments when they are
mv mv mv mv mv mv mv mv mv mv mv mv m
n ot rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer
v mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
prob lems with a morning appointment. Patients taking medication for systemic diseases may requir
mv mv mv mv mv mv mv mv mv mv mv mv mv
e speci al handling in the dental office.
mv mv mv mv mv mv mv
DIF: m v Comprehension
REF:
Role of the Dental Hygienist (Appointment Scheduling) |
mv mv mv mv mv mv mv mv
p. 3 OBJ:
mv mv 1 TOP:
NBDHE, 6.0. Pharmacology mv mv
,3. Nutritional or herbal supplements mv mv mv
a. carry the U.S. Food and Drug Administration (FDA) approval for disease states.
mv mv mv mv mv mv mv mv mv mv mv
b. are not drugs. mv mv
c. can cause adverse effects. mv mv mv
d. will not interact with other drugs the patient may be taking.
mv mv mv mv mv mv mv mv mv mv
ANS: C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritio
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
n al or herbal supplements do not carry FDA approval for treating disease states. These supplements
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
are drugs and can cause adverse effects and interact with different drugs.
mv mv mt mv mv mv mv mv mv mv mv
DIF: Comprehension
REF:
Role of the Dental Hygienist (Nutritional or Herbal Supplements) |
mv mv mv mv mv mv mv mv mv mv
p. 3 OBJ:
mv mv 1 TOP: NBDHE, 6.0. Pharmacology mv mv
4. Which type of drug name usually begins with a lowercase letter?
mv mv mv mv mv mv mv mv mv mv
a. Brand name mv
b. Code name mv
c. Generic name mv
d. Trade name mv
ANS: C
Before any drug is marketed, it is given a generic name that becomes the “official” name of the dru
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
g. Each drug is assigned only one generic name selected by the U.S. Adopted Name Council, and t
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
he na me is not capitalized. The brand name is equivalent to the trade name and is capitalized. Alth
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ough th e brand name is technically the name of the company marketing the product, this term is of
mv m v mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ten used int erchangeably with the trade name. The code name is the initial term used within a phar
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
maceutical co mpany to refer to a drug while it is undergoing investigation and is often a combinati
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
on of capital lett ers and numbers, the letters representing an abbreviation of the company name.
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: mv mv mv mv mv
3 TOP: mv
NBDHE, 6.0. Pharmacology m
v mv mv
5. A mv drug’s generic name is selected by the
mv mv mv mv mv mv
a. pharmaceutical company manufacturing it. mv mv mv
b. Food and Drug Administration (FDA).
mv mv mv mv
c. U.S. Adopted Name Council. mv mv mv
d. Federal Patent Office. mv mv
ANS: C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
Na me Council. The generic name is not selected by the FDA or the Federal Patent Office. The ph
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
armac eutical company manufacturing the drug clearly has an influence on the generic name given
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
its drug, but the final decision is not the company’s.
mv mv mv mv mv mv mv mv mv
DIF: Recall REF:
Drug Names | p. 4 OBJ:mv mv mv mv m v
3 TOP:
mv
NBDHE, 6.0. Pharmacology mv mv
6. Which of the following is true concerning generic and trade names of drugs?
mv mv mv mv mv mv mv mv mv mv mv mv
a. A drug may only have one generic name and one trade name.
mv mv mv mv mv mv mv mv mv mv mv
, b. A drug may only have one generic name, but it may have several trade names.
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
c. A drug may have several generic names, but it may only have one trade name.
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
d. A drug may have several generic names and several trade names.
mv mv mv mv mv mv mv mv mv mv
ANS: B
Each drug has only one generic name but may have several trade names. For each drug, there is on
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ly one generic name. It is not capitalized, and it becomes the “official” name of the drug. The phar
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
mace utical company discovering the drug gives the drug a trade name. The trade name is protecte
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
d by the Federal Patent Law for 20 years from the earliest claimed filing date, plus patent term exte
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
nsions. Alt hough the brand name is technically the name of the company marketing the product, it
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
is often used i nterchangeably with the trade name.
mv mv mv mv mv mv mv mv
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: mv mv mv mv mv
3 TOP: mv
NBDHE, 6.0. Pharmacology m
v mv mv
7. Two drugs that are found to be chemically equivalent, but not biologically equivalent
mv mv mv mv mv mv mv mv mv mv mv mv mv
or therapeutically equivalent are said to differ in
mv mv mv mv mv mv mv
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. mv
ANS: C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. Thes
mv mv mv mv mv mv mv mv mv mv mv mv
e products are said to differ in their bioavailability. The potency of a drug is a function of the amou
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mt mv mv mv
nt of drug required to produce an effect. The efficacy is the maximum intensity of effect or respon
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
se that can be produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of t
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
he experi mental animals divided by the effective dose for 50% of the experimental animals. If the
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
value of the therapeutic index is small, toxicity is more likely.
mv mv mv mv mv mv mv mv mv mv
DIF: Recall
REF: Drug Names (Drug Substitution) | p. 5 OBJ: mv mv mt mv mv mv mv
4 TOP: mv
NBDHE, 6.0. Pharmacology m
v mv mv
8. How many years must pass after a drug patent expires before other drug companies can market t
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
he same compound as a generic drug?
mv mv mv mv mv mv
a. 20 years mv
b. 17 years mv
c. 7 years mv
d. 0 years mv
ANS: D
Once a drug patent expires, competing companies may immediately market the same compound in
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ge neric form. The pharmaceutical company discovering the drug gives the drug a trade name. The
mv mv mv mv mv mv mt mv mv mv mv mv mv mv mv mv
trade name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date,
mv mv mv mt mv mv mv mv mv mv mv mv mv mv mt mv mv
plus th e patent term extensions.
mv mv mv mv mv mv
DIF: m v Application
REF: Drug Names (Drug Substitution) | p. 5 OBJ: mv mv mt mv mv mv mv
4 TOP: mv
NBDHE, 6.0. Pharmacology m
v mv mv
1. Knowledge of pharmacology aids the dental professional in
mv mv mv mv mv mv mv
a. obtaining a patient’s health history. mv mv mv mv
b. administering drugs in the office. mv mv mv mv
c. handling emergency situations. mv mv
d. selection of a nonprescription medication. mv mv mv mv
e. All of the above. mv mv mv
ANS: E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
of pharmacology helps in understanding and interpreting patients’ responses to health history questi
mv mv mv mv mv mv mv mv mv mv mv mv
ons. Knowledge of the therapeutic and adverse effects of medications obviously helps in their prop
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
er adm inistration in the office. Emergency situations may be caused by drugs or treated by drugs;
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
thus, kno wledge of pharmacology is of great help, especially because a rapid response is sometim
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
es required. A clear understanding of the concepts of drug action, drug handling by the body, and
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
drug interaction s will allow the dental practitioner to make proper judgments and grasp the concep
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ts relevant to new drug therapies on the market.
mv mv mv mv mv mv mv mv
DIF: Application m v
REF:
Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medicatio n
m v mv mv mv mv mv mv mv mv mv mv mv mv mv mv
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist (No
mv mv mv mv mv mv mv mv mv mv mv mv mv
nprescription Medication) | pp. 2-3
mv OBJ: mv1 mv mv mv
TOP: NBDHE, 6.0. Pharmacology m v mv mv
2. Which of the following statements is true regarding planning appointments?
mv mv mv mv mv mv mv mv mt
a. Whether or not patients are taking medication for systemic diseases is of litt
mv mv mv mv mv mv mv mv mv mv mv mv
le consequence in the dental office.
mv mv mv mv mv
b. Asthmatic patients should have dental appointments in the morning. mv mv mv mv mv mv mv mv
c. Diabetic patients usually have fewer problems with a morning appointment c
mv mv mv mv mv mv mv mv mv mv
o mpared with afternoon appointments.
mv mv mv mv
d. Both B and C are true. mv mv mv mv mv
ANS: D
Asthmatic patients who experience dental anxiety should schedule their appointments when they are
mv mv mv mv mv mv mv mv mv mv mv mv m
n ot rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer
v mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
prob lems with a morning appointment. Patients taking medication for systemic diseases may requir
mv mv mv mv mv mv mv mv mv mv mv mv mv
e speci al handling in the dental office.
mv mv mv mv mv mv mv
DIF: m v Comprehension
REF:
Role of the Dental Hygienist (Appointment Scheduling) |
mv mv mv mv mv mv mv mv
p. 3 OBJ:
mv mv 1 TOP:
NBDHE, 6.0. Pharmacology mv mv
,3. Nutritional or herbal supplements mv mv mv
a. carry the U.S. Food and Drug Administration (FDA) approval for disease states.
mv mv mv mv mv mv mv mv mv mv mv
b. are not drugs. mv mv
c. can cause adverse effects. mv mv mv
d. will not interact with other drugs the patient may be taking.
mv mv mv mv mv mv mv mv mv mv
ANS: C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritio
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
n al or herbal supplements do not carry FDA approval for treating disease states. These supplements
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
are drugs and can cause adverse effects and interact with different drugs.
mv mv mt mv mv mv mv mv mv mv mv
DIF: Comprehension
REF:
Role of the Dental Hygienist (Nutritional or Herbal Supplements) |
mv mv mv mv mv mv mv mv mv mv
p. 3 OBJ:
mv mv 1 TOP: NBDHE, 6.0. Pharmacology mv mv
4. Which type of drug name usually begins with a lowercase letter?
mv mv mv mv mv mv mv mv mv mv
a. Brand name mv
b. Code name mv
c. Generic name mv
d. Trade name mv
ANS: C
Before any drug is marketed, it is given a generic name that becomes the “official” name of the dru
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
g. Each drug is assigned only one generic name selected by the U.S. Adopted Name Council, and t
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
he na me is not capitalized. The brand name is equivalent to the trade name and is capitalized. Alth
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ough th e brand name is technically the name of the company marketing the product, this term is of
mv m v mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ten used int erchangeably with the trade name. The code name is the initial term used within a phar
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
maceutical co mpany to refer to a drug while it is undergoing investigation and is often a combinati
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
on of capital lett ers and numbers, the letters representing an abbreviation of the company name.
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: mv mv mv mv mv
3 TOP: mv
NBDHE, 6.0. Pharmacology m
v mv mv
5. A mv drug’s generic name is selected by the
mv mv mv mv mv mv
a. pharmaceutical company manufacturing it. mv mv mv
b. Food and Drug Administration (FDA).
mv mv mv mv
c. U.S. Adopted Name Council. mv mv mv
d. Federal Patent Office. mv mv
ANS: C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
Na me Council. The generic name is not selected by the FDA or the Federal Patent Office. The ph
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
armac eutical company manufacturing the drug clearly has an influence on the generic name given
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
its drug, but the final decision is not the company’s.
mv mv mv mv mv mv mv mv mv
DIF: Recall REF:
Drug Names | p. 4 OBJ:mv mv mv mv m v
3 TOP:
mv
NBDHE, 6.0. Pharmacology mv mv
6. Which of the following is true concerning generic and trade names of drugs?
mv mv mv mv mv mv mv mv mv mv mv mv
a. A drug may only have one generic name and one trade name.
mv mv mv mv mv mv mv mv mv mv mv
, b. A drug may only have one generic name, but it may have several trade names.
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
c. A drug may have several generic names, but it may only have one trade name.
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
d. A drug may have several generic names and several trade names.
mv mv mv mv mv mv mv mv mv mv
ANS: B
Each drug has only one generic name but may have several trade names. For each drug, there is on
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ly one generic name. It is not capitalized, and it becomes the “official” name of the drug. The phar
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
mace utical company discovering the drug gives the drug a trade name. The trade name is protecte
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
d by the Federal Patent Law for 20 years from the earliest claimed filing date, plus patent term exte
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
nsions. Alt hough the brand name is technically the name of the company marketing the product, it
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
is often used i nterchangeably with the trade name.
mv mv mv mv mv mv mv mv
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: mv mv mv mv mv
3 TOP: mv
NBDHE, 6.0. Pharmacology m
v mv mv
7. Two drugs that are found to be chemically equivalent, but not biologically equivalent
mv mv mv mv mv mv mv mv mv mv mv mv mv
or therapeutically equivalent are said to differ in
mv mv mv mv mv mv mv
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. mv
ANS: C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. Thes
mv mv mv mv mv mv mv mv mv mv mv mv
e products are said to differ in their bioavailability. The potency of a drug is a function of the amou
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mt mv mv mv
nt of drug required to produce an effect. The efficacy is the maximum intensity of effect or respon
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
se that can be produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of t
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
he experi mental animals divided by the effective dose for 50% of the experimental animals. If the
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
value of the therapeutic index is small, toxicity is more likely.
mv mv mv mv mv mv mv mv mv mv
DIF: Recall
REF: Drug Names (Drug Substitution) | p. 5 OBJ: mv mv mt mv mv mv mv
4 TOP: mv
NBDHE, 6.0. Pharmacology m
v mv mv
8. How many years must pass after a drug patent expires before other drug companies can market t
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
he same compound as a generic drug?
mv mv mv mv mv mv
a. 20 years mv
b. 17 years mv
c. 7 years mv
d. 0 years mv
ANS: D
Once a drug patent expires, competing companies may immediately market the same compound in
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
ge neric form. The pharmaceutical company discovering the drug gives the drug a trade name. The
mv mv mv mv mv mv mt mv mv mv mv mv mv mv mv mv
trade name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date,
mv mv mv mt mv mv mv mv mv mv mv mv mv mv mt mv mv
plus th e patent term extensions.
mv mv mv mv mv mv
DIF: m v Application
REF: Drug Names (Drug Substitution) | p. 5 OBJ: mv mv mt mv mv mv mv
4 TOP: mv
NBDHE, 6.0. Pharmacology m
v mv mv